Synthesis and Antitumor Activity of Novel Terephthalamide Derivatives

被引：0

作者：

Gu, Yifei ^{[1
,2
]}

Wu, Caiju ^{[1
]}

Wang, Siqi ^{[1
]}

Zhang, Shilin ^{[1
]}

Lu, Yuan ^{[1
]}

Si, Xinxin ^{[1
]}

Jiang, Bailing ^{[3
]}

机构：

[1] Jiangsu Ocean Univ, Coll Pharm, Jiangsu Key Laborratory Marine Pharmaceut Cpd Scre, Lianyungang 222005, Jiangsu, Peoples R China

[2] Jiangsu Inst Marine Resources Dev, Lianyungang 222005, Jiangsu, Peoples R China

[3] Second Peoples Hosp Lianyungang, Dept Pharm, Lianyungang 222005, Jiangsu, Peoples R China

来源：

CHINESE JOURNAL OF ORGANIC CHEMISTRY | 2024年 / 44卷 / 11期

关键词：

terephthalamide; antivity; synthesis;

D O I：

10.6023/cjoc202403049

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

In order to search for new structural antitumor drugs, a series of terephthalamide derivatives were designed and synthesized, and their antiproliferative activities against human tumor cell lines (PANC-1, MDA-MB-231 and SGC7901) were determined. N-1-(4-Methoxybenzyl)-N-4-(3-methoxyphenyl)-N-1-(3,4,5-trimethoxyphenyl)terephthalamide (TF) was identified as the most potent compound in antiproliferation against PANC-1 cells with the value of 0.13 mu mol/L, which was better than the positive control 5-fluorouracil (16.22 mu mol/L). Further mechanistic studies showed that compound TF could inhibit the clonal proliferation in a dose-dependent manner. In addition, compound TF can reduce the adhesive, migrational and invasive of PANC-1cells. These results indicated that compound TF might be developed the antitumor drug.

引用

页码：3497 / 3504

页数：8

共 15 条

[1] Cheng M., Yu X. F., Lu K., Xie L., Wang L., Meng F. Y., Han X. R., Chen X., Liu J., Xiong Y., Jin J., J. Med. Chem, 63, (2020)
[2] Qiao Q. H., Du Y. H., Xie L. H., Pharmacol. Res.-Mod. Chin. Med, 2, (2022)
[3] Hamze A., Alami M., Provot O., Eur. J. Med. Chem, 190, (2020)
[4] Ma L., Li M. L., Zhang Y. T., Liu K. D., Eur. J. Med. Chem, 261, (2023)
[5] Rozas I., Chem, 2, (2017)
[6] Li Y. R., Liu F. F., Liu W. B., Zhang Y. F., Tian X. Y., Fu X. J., Xu Y., Song J., Zhang S. Y., Biochem. Pharmacol, 201, (2022)
[7] Zhu H. J., Li W. L., Shuai W., Liu Y., Yang L. M., Tan Y. C., Zheng T. D., Yao H., Xu J. Y., Zhu Z. Y., Yang D. H., Chen Z. S., Xu S. T., Eur. J. Med. Chem, 216, (2021)
[8] Ma N., Qiao H., Tao H. C., Gan X. L., Shan Z. L., Chen X. M., Zhou X., J. Clin. Res. Hepatol. Gastroenterol, 46, (2022)
[9] He H. L., Hu X., Teng F., Liu Z. H., Zhang Q. S., Feng Z. Z., Feng Q., Yu L. T., Bioorg. Med. Chem. Lett, 30, (2020)
[10] Cao R. X., Jia Y. P., Chin. J. Org. Chem, 43, (2023)

← 1 2 →